Cambridge, MA · Founded 2019 · Privately Held (backing)
Developer of a genome-wide cell programming platform designed to convert patient-derived stem cells into multiple cell types. GC Therapeutics is based in Cambridge, MA and was founded in 2019. Its last known valuation is $135 million. It has raised $74.7 million.
Last price · $/share
—
Implied valuation
$135.0M
Total raised
$74.7M
Last round
—
Cap table — not yet on record
GC Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GC Therapeutics with a free account
·The complete investor list: 14 names
·Watch GC Therapeutics: the Monday email on marks, rounds and moves
